Abstract:<p>Spastic paraplegias (SPGs) are a group of clinically and genetically heterogeneous neurodegenerative diseases. Mutations in 78 genes have been identified in autosomal dominant hereditary SPG (AD-HSP) and autosomal recessive hereditary SPG (AR-HSP). Compared to familial HSP, much less is known about the genetic and clinical profiles of sporadic SPGs. In this study, we have screened mutations for 18 sporadic SPGs or AR-HSP patients (mainly Northern Chinese) by whole-exome sequencing. We identified 12 mutations in five genes in 9 (50%) patients, including 9 novel ones: SPG5A/CYP7B1 (c.851C>A; c.122+2T>G), SPG11/KIAA1840 (c.1735+3_ 1735+ 6del AAGT); SPG7/SPG7 (c.1454G>A; c.1892_ 1906dup GAGGACGGGCCTCGG); SPG39/PNPLA6 (c.1591G>A; c. 2990 C>T); SPG15/ ZFYVE26 (c. 4804C>T; c. 4278 G>A). Among all the mutations, 7 were detected in the SPG5A and SPG11. Age at onset was significantly younger in cases with mutations (15.45±6.78 years) than those without mutations (25.56±10.90 years) (P=0.03). Except for two cases with the SPG5A mutations, all cases presented with complicated SPGs. Three cases carrying mutations in SPG7, SPG15, SPG39 showed symptoms and signs of ataxia. One case carrying the homozygous c.259+2 T>C mutation in CYP7B1 showed serum parameters indicating liver impairment. Magnetic resonance imaging showed significantly thinned corpus callosum in cases with SPG11 and SPG15, but not in those with SPG5A, SPG7 or SPG39. In contrast, cerebellar atrophy was prominent in the SPG7 and SPG39 cases. These findings expand the spectrum of genetic, clinical and imaging features of sporadic SPG and AR-HSP, and have important implications in genetic counselling, molecular mechanisms and precise diagnosis of the disease.</p>

Clinical and genetic study of SPG6 mutation in a Chinese family with hereditary spastic paraplegia

Expansion of the Phenotypic Spectrum of SPG6 Caused by Mutation in NIPA1.

Mutation and Clinical Characteristics of Autosomal-Dominant Hereditary Spastic Paraplegias in China

Three Novel Mutations of the Spastin Gene in Chinese Patients with Hereditary Spastic Paraplegia

Characteristics of Clinical and Spastin Gene Mutation in a Family with Hereditary Spastic Paraplegia

[Spastin Gene Mutation in Chinese Patients with Hereditary Spastic Paraplegia].

Novel Mutations in the SPAST Gene Cause Hereditary Spastic Paraplegia.

Genetic Analysis of SPG4 and SPG3A Genes in a Cohort of Chinese Patients with Hereditary Spastic Paraplegia.

Analysis on Mutations of Spastin, Atlastin and Paraplegin Genes in Chinese Patients with Hereditary Spastic Paraplegia

[The Clinical Characteristics of a Pedigree with Incompletely Penetrated Autosomal Dominant Hereditary Spastic Paraplegia and Its Exclusion Analysis of Genetic Loci].

A Novel Candidate Locus on Chromosome 11P14.1-P11.2 for Autosomal Dominant Hereditary Spastic Paraplegia

Molecular genetics study of hereditary spastic paraplegia accompanied by distal amyotrophy-an update

Exon 8-17 Deletions of Spast in A Chinese Family with Hereditary Spastic Paraplegia: A Case Report and Literature Review

Distinct novel mutations affecting the same base in the NIPA1 gene cause autosomal dominant hereditary spastic paraplegia in two Chinese families.

Receptor Expression-Enhancing Protein 1 Gene (SPG31) Mutations Are Rare in Chinese Han Patients with Hereditary Spastic Paraplegia.

Genetic, clinical and neuroimaging profiles of sporadic and autosomal recessive hereditary spastic paraplegia cases in Chinese

Clinical Features and Genetic Spectrum in Chinese Patients with Recessive Hereditary Spastic Paraplegia

Chinese Families with Autosomal Recessive Hereditary Spastic Paraplegia Caused by Mutations in SPG11

Novel mutation of SPG4 gene in a Chinese family with hereditary spastic paraplegia: A case report

Mutation and Polymorphism Analysis of SPG4 and SPG3A in Chinese Patients with Hereditary Spastic Paraplegia

Two Novel Mutations in the Spastin Gene of Chinese Patients with Hereditary Spastic Paraplegia